Inhibitory Effect of Cudratrixanthone U on RANKL-Induced Osteoclast Differentiation and Function in Macrophages and BMM Cells

Keyphrases

• Inhibitory Effect 100%
• Macrophages 100%
• Osteoclast Differentiation 100%
• Osteoclast Function 100%
• Osteoclast 75%
• Prenylated Xanthones 75%
• RAW264.7 Macrophages 50%
• Bone Resorption 50%
• Osteoporosis 50%
• Cause of Disease 25%
• Dendritic Cells 25%
• Potential Therapeutics 25%
• Transmembrane Protein 25%
• Biological Activity 25%
• Cathepsin K 25%
• Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) 25%
• Matrix metalloproteinase-9 (MMP-9) 25%
• Receptor Activator of nuclear factor-B Ligand 25%
• Chemokines 25%
• Bone Disease 25%
• Specific Genes 25%
• Precoding Matrix 25%
• TAK1 25%
• Moraceae 25%
• Maclura Tricuspidata 25%
• Osteoclast Formation 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Osteoclast Differentiation Factor 100%
• Xanthone Derivative 100%
• Disease 33%
• Receptor 33%
• Biological Activity 33%
• Alternative Complement Pathway C3 C5 Convertase 33%
• Tumor Necrosis Factor Receptor Associated Factor 6 33%
• Nuclear Factor 33%
• Cathepsin K 33%
• Matrix Metalloproteinase 33%
• Moraceae 33%
• Beta Chemokine 33%
• Bone Disease 33%
• Maclura 33%

Immunology and Microbiology

• Macrophage 100%
• Osteoclastogenesis 100%
• RANKL 100%
• Osteoclast 75%
• Osteolysis 50%
• Dendritic Cell 25%
• Biological Activity 25%
• Beta Chemokine 25%
• Complement Factor B 25%
• Moraceae 25%
• Maclura 25%